BSE Live
Nov 14, 16:01Prev. Close
266.95
Open Price
267.20
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Nov 14, 15:48Prev. Close
267.25
Open Price
267.25
Bid Price (Qty.)
262.90 (40)
Offer Price (Qty.)
0.00 (0)
| Key Financial Ratios of Indoco Remedies (in Rs. Cr.) | Mar 15 | Mar 14 | Mar 13 | Mar 12 | Mar 11 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | 8.99 | 6.28 | 4.63 | 37.72 | 41.60 | |
| Diluted EPS (Rs.) | 8.99 | 6.28 | 4.63 | 37.72 | 41.60 | |
| Cash EPS (Rs.) | 14.10 | 9.64 | 7.20 | 53.38 | 52.55 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 56.25 | 49.59 | 44.93 | 313.15 | 285.02 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 56.25 | 49.59 | 44.93 | 313.15 | 285.02 | |
| Dividend / Share(Rs.) | 1.60 | 1.40 | 1.10 | 5.50 | 8.00 | |
| Revenue from Operations/Share (Rs.) | 92.63 | 78.97 | 68.41 | 462.92 | 391.53 | |
| PBDIT/Share (Rs.) | 18.12 | 13.22 | 10.20 | 70.68 | 57.43 | |
| PBIT/Share (Rs.) | 13.00 | 9.87 | 7.62 | 55.02 | 46.48 | |
| PBT/Share (Rs.) | 11.88 | 7.83 | 5.25 | 41.72 | 46.05 | |
| Net Profit/Share (Rs.) | 8.99 | 6.28 | 4.63 | 37.72 | 41.60 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 19.55 | 16.74 | 14.90 | 15.26 | 14.66 | |
| PBIT Margin (%) | 14.03 | 12.49 | 11.14 | 11.88 | 11.87 | |
| PBT Margin (%) | 12.82 | 9.90 | 7.67 | 9.01 | 11.76 | |
| Net Profit Margin (%) | 9.70 | 7.95 | 6.76 | 8.14 | 10.62 | |
| Return on Networth / Equity (%) | 15.97 | 12.67 | 10.30 | 12.04 | 14.59 | |
| Return on Capital Employed (%) | 14.20 | 10.99 | 8.66 | 9.76 | 11.55 | |
| Return on Assets (%) | 9.84 | 7.97 | 6.18 | 7.06 | 9.07 | |
| Total Debt/Equity (X) | 0.17 | 0.15 | 0.22 | 0.23 | 0.22 | |
| Asset Turnover Ratio (%) | 101.43 | 100.22 | 91.44 | 86.65 | 85.41 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 1.48 | 1.51 | 1.39 | 1.45 | 1.87 | |
| Quick Ratio (X) | 0.91 | 0.97 | 0.91 | 0.89 | 1.20 | |
| Inventory Turnover Ratio (X) | 5.84 | 6.72 | 6.80 | 5.58 | 5.98 | |
| Dividend Payout Ratio (NP) (%) | 17.80 | 22.28 | 23.76 | 21.87 | 19.22 | |
| Dividend Payout Ratio (CP) (%) | 11.34 | 14.52 | 15.27 | 15.45 | 15.22 | |
| Earnings Retention Ratio (%) | 82.20 | 77.72 | 76.24 | 78.13 | 80.78 | |
| Cash Earnings Retention Ratio (%) | 88.66 | 85.48 | 84.73 | 84.55 | 84.78 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 3,416.61 | 1,358.87 | 611.50 | 576.29 | 599.96 | |
| EV/Net Operating Revenue (X) | 4.00 | 1.87 | 0.97 | 1.01 | 1.25 | |
| EV/EBITDA (X) | 20.47 | 11.15 | 6.51 | 6.64 | 8.50 | |
| MarketCap/Net Operating Revenue (X) | 3.92 | 1.79 | 0.85 | 0.88 | 1.14 | |
| Retention Ratios (%) | 82.19 | 77.71 | 76.23 | 78.12 | 80.77 | |
| Price/BV (X) | 6.45 | 2.85 | 1.29 | 1.30 | 1.56 | |
| Price/Net Operating Revenue | 3.92 | 1.79 | 0.85 | 0.88 | 1.14 | |
| Earnings Yield | 0.02 | 0.04 | 0.08 | 0.09 | 0.09 |
12.11.2025
Indoco Remedies Standalone September 2025 Net Sales at Rs 442.12 crore, up 11.5% Y-o-Y
07.11.2025
Indoco Remedies Consolidated September 2025 Net Sales at Rs 484.67 crore, up 12.02% Y-o-Y
25.07.2025
24.07.2025
Indoco Remedies Consolidated June 2025 Net Sales at Rs 437.89 crore, up 1.48% Y-o-Y
12.11.2025
Indoco Remedies Standalone September 2025 Net Sales at Rs 442.12 crore, up 11.5% Y-o-Y
07.11.2025
Indoco Remedies Consolidated September 2025 Net Sales at Rs 484.67 crore, up 12.02% Y-o-Y
24.07.2025
Indoco Remedies Consolidated June 2025 Net Sales at Rs 437.89 crore, up 1.48% Y-o-Y
24.07.2025
Indoco Remedies Standalone June 2025 Net Sales at Rs 392.53 crore, down 2.22% Y-o-Y
12.07.2023
Indoco Remedies Q1 PAT may dip 0.1% YoY to Rs 38.5 cr: Nirmal Bang
17.01.2023
Indoco Remedies Q3 PAT seen up 46.1% YoY to Rs 482 cr: Nirmal Bang
08.07.2022
Indoco Remedies Q1 PAT seen up 4.4% YoY to Rs 41.4 cr: Prabhudas Lilladher
14.04.2022
Indoco Remedies Q4 PAT seen up 52.9% YoY to Rs 38.2 cr: Prabhudas Lilladher